The evaluation of the tumor marker CYFRA 21-1 in the differentiation of malignant and benign pulmonary lesions (CROSBI ID 573169)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Pavićević, Radomir ; Bubanović, Gordana ; Krajna, Ana ; Miličić, Jasna ; Pavelić, Ljubomir ; Stančić-Rokotov, Dinko ; Bobić, Jasminka
engleski
The evaluation of the tumor marker CYFRA 21-1 in the differentiation of malignant and benign pulmonary lesions
Cytokeratin marker CYFRA 21-1 has proven itself as a useful tool in prognosis , therapy and detection of relapse in our clinical research. This paper we will show its usefulness in differential diagnosis in 254 patients with nodose pulmonary lesion. In 37.40% we found benign pulmonary lesions, while in 37.80% we found metastases (colo, larynx, kidney, etc). 24.80% of our patients were diagnostically nonverified. The value of cytokeratin marker CYFRa 21-1 was determined...
Lung cancer; CYFRA 21-1; pulmonary lesion
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
66-66.
2001.
objavljeno
Podaci o matičnoj publikaciji
New York (NY): American Thoracic Society (ATS)
Podaci o skupu
ATS 97th International Conference
poster
18.05.2001-23.05.2001
San Francisco (CA), Sjedinjene Američke Države
